101 results
Page 4 of 6
6-K
EX-4.4
qzf8vadm fhj2qvxfs
10 Feb 20
Current report (foreign)
7:20am
6-K
EX-10.2
qbtt22in2e3znfy58a
10 Feb 20
Current report (foreign)
7:20am
6-K
EX-99.1
0s62ymthy qynt
13 Jan 20
Mereo BioPharma and Oncologie Enter into Global Licensing Agreement for Navicixizumab
8:26am
6-K
EX-10.1
vpg6ffg199fjff9
3 Sep 19
Current report (foreign)
4:05pm
6-K
lpagfdoy4uf
3 Sep 19
Current report (foreign)
4:05pm
S-8
EX-99.1
qd6pkz7e bv
21 May 19
Registration of securities for employees
1:53pm
20-F
EX-4.19
lbartz
29 Apr 19
Annual report (foreign)
4:59pm
20-F
EX-4.17.1
p2f5hxvjjhwekvb
29 Apr 19
Annual report (foreign)
4:59pm
20-F
EX-4.13.1
ory2jhm8
29 Apr 19
Annual report (foreign)
4:59pm
20-F
EX-4.7
xu39rkbn9foz401i
29 Apr 19
Annual report (foreign)
4:59pm
20-F
sk9t2std oyovwapm3a1
29 Apr 19
Annual report (foreign)
4:59pm
6-K
fyteer38bhctli9 h1
29 Apr 19
Current report (foreign)
12:09pm
6-K
wqcdpytbf99 zl
23 Apr 19
Current report (foreign)
4:14pm
424B3
60vz3p2adqc 0u9wy8
20 Mar 19
Prospectus supplement
4:58pm
F-4/A
253e05oe 6y
15 Mar 19
Registration of securities (foreign) (amended)
5:08pm
425
m7jx 3sqz
15 Mar 19
Business combination disclosure
8:34am
425
fobgfv057tqc0n6ttu
12 Mar 19
Business combination disclosure
9:27am
425
z5l z9cg8d
15 Feb 19
Business combination disclosure
6:50am
425
duvos68zqykfgrtwmk
12 Feb 19
Business combination disclosure
12:00am
F-4
EX-10.20
ijchz8
25 Jan 19
Registration of securities (foreign)
12:00am